🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today, we released our Q2 FY24 financial results. For our full update: lnkd.in/gArHtxZE #GrowWithAurora

On February 8, 2024 Aurora will announce its third quarter of fiscal year 2024 financial results. More details here: lnkd.in/gnrn8mtf

Aurora has acquired MedReleaf Australia, a leader in Australia's fast-growing medical #cannabis market. This strategic step will combine our global expertise with MedReleaf’s local strength to accelerate growth, improve patient care, and expand cannabis access. lnkd.in/g9Myc62X

MedReleaf Australia has been acquired by Aurora Cannabis, a global leader in medical cannabis & a long-standing partner to us. Read more about this exciting announcement here -auroramj.com/press-releases…

“Australia has grown steadily and now is about the same size as Canada – so it’s probably one of the top two federally legal medical cannabis markets in the world,” said Miguel Martin, our CEO in a chat with Matt Lamers MJBiz following our big news. rebrand.ly/qdvph48

🌿 Big Moves in Cannabis 🌿 Aurora Cannabis is making waves with a 41% increase in international medical cannabis revenue and a strategic expansion in Australia. Takeaways from today's episode: 🌿Aurora's strong growth with CA$64.4 million in net revenue for Q3. 🌿Their latest

Thrilled to Congratulate Paul McCarthy on Becoming President of Cannabis Council of Canada! His leadership will drive positive growth and innovation in the industry. Join us in celebrating! #Cannabis #Leadership #Congratulations bit.ly/3VIPrVz

We're thrilled to share that our first shipment of medical cannabis has reached the New Zealand market! This marks a significant milestone in our mission of #OpeningTheWorldToCannabis. Read more about this in our press release: [newswire.ca/news-releases/…]

We’re thrilled to launch our premium resin cartridges in Australia! These high-potency, flavourful cartridges offer patients a unique and effective cannabis experience, developed with the highest quality and safety standards. Full press release here: shorturl.at/oAMdl

Today we released our Q4 FY24 Results: - Record annual Adjusted EBITDA of $12.8M - Quarterly net revenue up 5% YoY to $67.4M - Global medical cannabis revenue grew 20% YoY to $45.6M - Ended FY24 with ~$180M cash, debt-free 🔗 Full update: shorturl.at/Y0ve5

Today’s news - Aurora is teaming up with VecturaFertin to launch a new CBD lozenge in Canada, hitting our Canadian medical cannabis patient platform later this year. This collaboration promises to elevate patient care and drive innovation in medical cannabis. #GrowWithAurora

Excited to share our Q1 Fiscal 2025 results! Highlights: Revenue: +12% YoY to $83.4M Global Medical: Record $47.2M (+13% YoY) Bevo Revenue: $23.1M (+16% YoY) International Sales: +$5.6M Cash: $182M, debt-free EBITDA: +87% to $4.9M Read more: shorturl.at/nXvq2

Aurora announces key leadership updates. Details: shorturl.at/2SCCy Miguel Martin expands role to CEO and Executive Chairman, while Ron Funk steps in as Lead Independent Director. This change reinforces strong governance and supports Aurora's growth in medical cannabis.

Today we released Q2 FY2025 results, showcasing strong performance and leadership in cannabis $10.1M Record Adjusted EBITDA $81.1M in total quarterly net revenue $61.3M Record Global Medical Cannabis Revenue $152M cash, debt-free business Details: [shorturl.at/PUmxe]

Our River facility recently held a Safety Day where employees led activities on ergonomics, fire safety & more. The day reinforced our commitment to fostering a safe, healthy workplace. #WorkplaceSafety